Research and Markets: Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Pipeline Insights 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/288t3q/rho_kinase) has announced the addition of the "Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors -Pipeline Insights, 2014" subscription to their offering.

Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors-Pipeline Insights, 2014 provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors. This report provides information on the therapeutic development based on the Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Overview
  2. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Disease Associated
  3. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Pipeline Therapeutics
  4. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Therapeutics under Development by Companies
  5. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Late Stage Products (Filed and Phase III)
  6. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Mid Clinical Stage Products (Phase II)
  7. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
  8. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors Discovery and Pre-Clinical Stage Products
  9. Drug Candidate Profiles
  10. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors - Therapeutics Assessment
  11. Assessment by Monotherapy Products
  12. Assessment by Combination Products
  13. Assessment by Route of Administration
  14. Assessment by Molecule Type
  15. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors - Discontinued Products
  16. Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors - Dormant Products
  17. Companies Involved in Therapeutics Development for Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors

For more information visit http://www.researchandmarkets.com/research/288t3q/rho_kinase

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals